These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2678041)

  • 21. After radiotherapy testosterone stimulation is unable to increase growth in the dunning R3327-PAP prostate tumour.
    Granfors T; Tomic R; Bergh A; Rydh M; Löfroth PO; Widmark A
    Urol Res; 1999 Oct; 27(5):357-61. PubMed ID: 10550524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of estramustine phosphate upon cell proliferation in mouse accessory sex glands.
    Alison MR; Wright NA
    J Endocrinol; 1980 Nov; 87(2):203-12. PubMed ID: 6159443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
    Johansson A; Jones J; Pietras K; Kilter S; Skytt A; Rudolfsson SH; Bergh A
    Prostate; 2007 Nov; 67(15):1664-76. PubMed ID: 17854058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormonal and chemotherapeutic treatment of prostatic carcinoma; Dunning adenocarcinoma of the prostate in Copenhagen-Fischer rats.
    Rosenberg CA; Hrushesky WJ; Langevin T; Kennedy BJ
    Oncology; 1985; 42(1):48-54. PubMed ID: 3969257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of cytotoxic steroids for prostate cancer.
    Petrow V; Padilla GM
    Prostate; 1986; 9(2):169-82. PubMed ID: 3748896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumorigenesis disrupts hormonal regulation of tenascin expression in regressing Dunning R 3327 H prostate carcinoma.
    Vollmer G; Michna H; Schneider MR
    Cancer Lett; 1996 Mar; 101(2):185-92. PubMed ID: 8620468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen treatment of Dunning tumors in castrated rats: qualitative and quantitative morphology.
    Landström M; Bergh A; Thornell LE; Virtanen I; Damber JE
    Prostate; 1992; 20(3):199-211. PubMed ID: 1574467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of cyproterone acetate and estramustine phosphate on the plasma levels of testosterone and gonadotrophic hormones in adenocarcinoma of the prostate].
    Alfonso Sánchez M; Pérez Herrero F; Urrutia Avisrror M; Vega Wong J; Lago Montero A
    Actas Urol Esp; 1986; 10(2):111-6. PubMed ID: 2942009
    [No Abstract]   [Full Text] [Related]  

  • 29. Unusual androgen sensitivity of the androgen-independent Dunning R-3327-G rat prostatic adenocarcinoma: androgen effect on tumor cell loss.
    Humphries JE; Isaacs JT
    Cancer Res; 1982 Aug; 42(8):3148-56. PubMed ID: 7093958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer.
    Smolev JK; Heston WD; Scott WW; Coffey DS
    Cancer Treat Rep; 1977; 61(2):273-87. PubMed ID: 872132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific binding of estramustine to prostatic proteins.
    Forsgren B; Björk P
    Urology; 1984 Jun; 23(6 Suppl):34-8. PubMed ID: 6375077
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
    Yamanaka H; Shida K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen treatment postpones the castration-induced dedifferentiation of Dunning R3327-PAP prostatic adenocarcinoma.
    Landström M; Damber JE; Bergh A
    Prostate; 1994 Jul; 25(1):10-8. PubMed ID: 8022707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of pituitary and adrenocortical hormones on prostatic secretion protein, a major protein in rat prostate.
    Pousette A; Björk P; Carlström K; Forsgren B; Högberg B; Gustafsson JA
    Prostate; 1982; 3(2):109-14. PubMed ID: 7088730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of androgen deprivation and estrogen treatment on the structure and protein expression of the rat coagulating gland.
    Holterhus PM; Zhao GQ; Aumüller G
    Anat Rec; 1993 Feb; 235(2):223-32. PubMed ID: 8093591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of transforming growth factor-beta 1 in rat ventral prostate and Dunning R3327 PAP prostate tumor after castration and estrogen treatment.
    Lindström P; Bergh A; Holm I; Damber JE
    Prostate; 1996 Oct; 29(4):209-18. PubMed ID: 8876704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition by estramustine phosphate on estradiol and androgen binding in benign and malignant prostate in humans.
    Nilsson I; Liskowski L; Nilsson T
    Urology; 1976 Aug; 8(2):118-21. PubMed ID: 60819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
    Sylvester PW; Ip MM
    Prostate; 1987; 10(1):57-67. PubMed ID: 3822918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estramustine binding protein and anti-proliferative effect of estramustine in human glioma cell lines.
    von Schoultz E; Lundblad D; Bergh J; Grankvist K; Henriksson R
    Br J Cancer; 1988 Sep; 58(3):326-9. PubMed ID: 3052561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estramustine phosphate: metabolic aspects related to its action in prostatic cancer.
    Kadohama N; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1978 Feb; 119(2):234-9. PubMed ID: 633484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.